In Melanoma,RASMutations Are Accompanied by Switching Signaling From BRAF to CRAF and Disrupted Cyclic AMP Signaling

Cancer Research - United States
doi 10.1158/0008-5472.can-05-4227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Differential Signaling of Cyclic AMP

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing Cyclic AMP Levels

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

BRAF Inactivation Drives Aneuploidy by Deregulating CRAF

Cancer Research
Cancer ResearchOncology
2010English

Disrupted Signaling Networks in Cancer

Science
MultidisciplinaryPhilosophy of ScienceHistory
2015English

Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Frontiers in Oncology
Cancer ResearchOncology
2015English

Genetic Association of Cyclic AMP Signaling Genes With Bipolar Disorder

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2012English

Farnesol and Cyclic AMP Signaling Effects on the Hypha-To-Yeast Transition in Candida Albicans

Eukaryotic Cell
2012English

Melatonin Synergizes BRAF-targeting Agent Vemurafenib in Melanoma Treatment by Inhibiting iNOS/hTERT Signaling and Cancer-Stem Cell Traits

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy